Drug Channels

OCTOBER 21, 2024

Vital insights from industry’s leading pharmacy and distribution experts, including: Bill Roth, Senior Vice President of Consulting, Blue Fin Group, An IntegriChain Company Patrick Lupo Group Vice President, Pharmacy Trade and Specialty, Walgreens Amanda Salindong, Associate Director, Channel & Distribution, Alnylam Pharmaceuticals Chris Rocco, (..)

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Marketing Compliance 98

Drug Channels

APRIL 8, 2022

Michael discusses patient support challenges that are unique to specialty-lite pharmaceuticals. He goes on to describe four new categories of patient solutions and pharmacy models specific to this growing market segment.

Specialty Pharmacies 96

Specialty Pharmacies Production Pharmacy Therapies 96

Drug Channels

SEPTEMBER 13, 2023

For 2023, specialty pharmacies—via white, brown, and clear bagging—retained a meaningful share of the distribution channels for provider-administered oncology drugs. Time for our annual update on the channels for provider-administered drugs. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Specialty Pharmacies 97

Specialty Pharmacies Pharmacy Pharmaceuticals Drugs 97

Drug Channels

DECEMBER 13, 2023

For 2023, specialty pharmacies—via white, brown, and clear bagging—retained a meaningful share of the distribution channels for provider-administered oncology drugs. This week, I’m rerunning some popular posts while I prepare for Fiday's Drug Channels Outlook 2024 live video webinar. d/b/a Drug Channels Institute.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Pharmaceuticals Drugs 98

Drug Channels

SEPTEMBER 11, 2024

For 2024, payers report that specialty pharmacies—via white and clear bagging—have displaced buy-and-bill for a meaningful share of commercial covered lives utilizing provider-administered oncology drugs. Below, I review the latest data on 2024 trends and compare them to the pre-pandemic figures. drug channels.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Pharmaceuticals Drugs 52

Drug Channels

OCTOBER 2, 2024

This week, I’m rerunning some popular posts while we put the finishing touches on DCI’s new 2024-25 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. The 340B contract pharmacy market shows little sign of slowing down. Click here to see the original post from June 2024.

Pharmacy 52

Pharmacy Specialty Pharmacies Hospitals Marketing 52

Drug Channels

MARCH 15, 2022

Licenses for our DCI reports are regularly purchased by nearly every company involved in the drug channel: pharmaceutical manufacturers, wholesalers, pharmacists, pharmacy owners, hospitals, buyers, benefit managers, managed care executives, policy analysts, investors, consultants, and more.

Pharmacy 98

Pharmacy Specialty Pharmacies Licensing Licensing 98

Drug Channels

SEPTEMBER 21, 2020

This important event convenes key stakeholders including manufacturers, specialty pharmacies, hubs, payers, PBMs, physicians and more to explore strategies for developing and integrating hub programs and other patient-centric services to ensure product access and optimal reimbursement. Arquette, R.Ph., REGISTER TODAY.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Pharmaceuticals Production 52

Drug Channels

JULY 20, 2021

The 340B Drug Pricing Program continues to expand far more quickly than the overall pharmaceutical market—and some channels are benefiting more than others. As you will see below, mail and specialty pharmacies’ purchases of products that are eligible for 340B discounts have grown by an incredible 56% per year since 2017.

Specialty Pharmacies 40

Specialty Pharmacies Pharmacy Marketing Pharmaceuticals 40

Drug Channels

JANUARY 4, 2021

Dave MacLeod, Head of Patient Services and Specialty Pharmacy Operations , Amylyx Pharmaceuticals Deepti Jaggi, Global Head of Patient Insights and Solutions , Astellas US Marina Allen, Executive Director, Patient Access and Reimbursement , Coherus BioSciences And more!

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Pharmaceuticals Drugs 52

Drug Channels

APRIL 11, 2021

Koob, Assistant U.S. Attorney , U.S. Attorney’s Office for the Eastern District of Pennsylvania Jolie Apicella, Assistant U.S. Attorney, Chief, Health Care Fraud , U.S.

Specialty Pharmacies 40

Specialty Pharmacies Compliance Pharmacy Pharmaceuticals 40

Drug Channels

APRIL 19, 2021

Up your compliance game at this important event serving the unique sector of Specialty Products, the 7th annual Virtual Compliance Congress for Specialty Products.

Compliance 40

Compliance Production Specialty Pharmacies Pharmacy 40

The Pharma Data

JANUARY 12, 2021

Akin to the NASA Deep Space Network, SYNERGY-AI OCTCC is a real time data and communication network between patients, sites, and pharmaceutical companies, with the Massive Bio AI-enabled engine orchestrating these stakeholders for successful operations. NEW YORK–( BUSINESS WIRE )– Massive Bio, Inc. , 75N91020C00016.

Clinical Trials 52

Clinical Trials Trials Clinical Research Pharmaceutical Companies 52

The Pharma Data

OCTOBER 27, 2020

We commenced launch activities for the Remunity Pump for Remodulin, including shipping training devices to specialty pharmacies and certain health care practitioners, and entering into agreements with specialty pharmacies to purchase Remunity Pumps and accessories and to pre-fill the Remunity cartridges exclusively with Remodulin.

FDA 40

FDA Production Licensing Licensing 40

Drug Channels

OCTOBER 19, 2020

Gain Critical Insight from Industry Trailblazers During a Time of Transformative Change – Speakers will include : Bill Roth, Founding Partner, Blue Fin Group Rob Osborne, Vice President Pharma Trade Relations, Express Scripts, Accredo, CuraScript SD Ray Tancredi, RPh, MBA, CSP, Divisional Vice President, Specialty Pharmacy Development & Brand Rx/Vaccine (..)

Science 52

Science Specialty Pharmacies Pharmacy Licensing 52

Drug Channels

OCTOBER 10, 2023

I am pleased to announce our new 2023–24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. pharmaceutical distribution industry. we analyze the IRA’s likely consequences for wholesalers and the overall pharmaceutical business. and Section 6.4.3.

Pharmaceuticals 40

Pharmaceuticals Specialty Pharmacies Pharmacy Biosimilars 40

Drug Channels

NOVEMBER 8, 2020

Stuart Parker, Senior Director, Trade Relations, Mayne Pharma And more!

Specialty Pharmacies 52

Specialty Pharmacies Science Pharmacy Pharmaceuticals 52

The Pharma Data

APRIL 4, 2023

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the availability of an additional tablet strength of ERLEADA ® (apalutamide) in the United States. Both tablet strengths are available via prescription through existing specialty pharmacy networks. FDA approval for mCSPC in September 2019.To

Specialty Pharmacies 40

Specialty Pharmacies FDA Approval Pharmaceutical Companies Pharmacy 40

Drug Channels

APRIL 23, 2025

Last week, we examined the growing concentration of specialty drug dispensing revenues among the largest pharmacies. See The Top 15 Specialty Pharmacies of 2024: How PBMs, Health Systems, and Independents Are Shaping the Market. Today, we dive deeper. Drawing from DCIs new 2025 Economic Report on U.S.

Pharmacy 72

Pharmacy Specialty Pharmacies Independent Pharmacies Pharmaceuticals 72

Drug Channels

APRIL 15, 2025

In todays fast-moving pharmaceutical marketplace, insight is everything. Why Professionals Choose DCI eLearning These modules were built from the ground up for pharmaceutical professionalsfrom seasoned experts to newcomers looking to understand the industry's complex web of relationships. pharmaceutical distribution.

Specialty Pharmacies 52

Specialty Pharmacies Pharmaceuticals Pharmacy Licensing 52

Drug Channels

DECEMBER 12, 2024

For 2024, payers report that specialty pharmaciesvia white and clear bagginghave displaced buy-and-bill for a meaningful share of commercial covered lives utilizing provider-administered oncology drugs. Payers adoption of white baggingand providers push backreflect the ongoing battle for oncology margin in U.S. drug channels. drug channels.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Pharmaceuticals Drugs 52

Drug Channels

MARCH 18, 2025

Weve updated all market and industry data with the most current insights, including our annual analyses of the largest pharmacies, specialty pharmacies, and PBMs. WHATS GOING ON Twice a year, the DCI team researches and writes two comprehensive, fact-based, and nonpartisan reports on drug channel economics.

Pharmacy 52

Pharmacy Specialty Pharmacies Licensing Licensing 52